Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression.

The objective of this review is to discuss the relationship between brain insulin resistance and depression, as well as possible disease modifying therapeutic agents targeting insulin signalling.
PMID: 30695707 [PubMed - as supplied by publisher]

Source: Experimental Neurology - January 26, 2019 Category: Neurology Authors: Hamer JA, Testani D, Mansur RB, Lee Y, Subramaniapillai M, McIntyre RS Tags: Exp Neurol Source Type: research